BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31884798)

  • 1. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
    Guo CM; Liu SQ; Sun MZ
    Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A4 and cancer.
    Wei B; Guo C; Liu S; Sun MZ
    Clin Chim Acta; 2015 Jul; 447():72-8. PubMed ID: 26048190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of annexin A7 in cancers.
    Guo C; Liu S; Greenaway F; Sun MZ
    Clin Chim Acta; 2013 Aug; 423():83-9. PubMed ID: 23639634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues.
    Wang L; Yu J; Xu J; Zheng C; Li X; Du J
    Gene; 2015 Jan; 554(1):1-8. PubMed ID: 25452192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers.
    Sharma PC; Gupta A
    Transl Cancer Res; 2020 Sep; 9(9):5798-5818. PubMed ID: 35117940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
    Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Study on Signal Transduction and Therapeutic Role of miR-877 in Human Cancers.
    Rafat M; Kohsarian M; Bahiraei M; Nikpoor AR
    Adv Biomed Res; 2023; 12():118. PubMed ID: 37434921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.
    Li D; Liu K; Li Z; Wang J; Wang X
    Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
    Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O
    Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of miR-802 in tumors.
    Gao T; Zou M; Shen T; Duan S
    J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
    Jia LF; Gan YH; Yu GY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1.
    Li Y; Chen X
    Biochem Biophys Res Commun; 2015 Dec; 468(4):863-9. PubMed ID: 26585487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.